GlassScriptPhysician profile
Carrie Flury
NPI 1841287471
$1,688.60
in general payments reported to CMS, 2019-2025
17 companies · $755 in 2025
The $755 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.05 · 2022: $42.54 · 2024: $872 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,427 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,427.03 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $606.82 | 2024-2025 | Tremfya, Simponi, Stelara |
| Regeneron Healthcare Solutions, INC. | $243.16 | 2024-2025 | Dupixent |
| Abbvie INC. | $159.42 | 2024-2025 | |
| Lilly USA, LLC | $132.54 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Galderma Laboratories, L.P. | $104.17 | 2024-2025 | Nemluvio |
| E.R. Squibb & Sons, L.L.C. | $101.69 | 2024-2025 | Sotyktu |
| Genzyme Corporation | $60.58 | 2024-2025 | |
| Krystal Biotech INC | $52.39 | 2024-2025 | Vyjuvek |
| Novo Nordisk INC | $42.54 | 2022 | |
| Amgen INC. | $37.70 | 2025 | Otezla, Otezla |
| Incyte Corporation | $32.26 | 2024 | Opzelura |
| Ucb, INC. | $26.82 | 2024 | Bimzelx |
| Merz North America, INC. | $21.64 | 2024 | |
| Pfizer INC. | $19.05 | 2021 | |
| Sandoz INC. | $18.81 | 2024 | Hyrimoz |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.37 | 2024 | |
| Fresenius Kabi USA, LLC | $13.64 | 2024 | Idacio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Flury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.